Page last updated: 2024-12-06

procion blue mx-r

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

procion blue MX-R: used in affinity labeling of enzymes; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID25863
CHEMBL ID1741102
SCHEMBL ID430581
MeSH IDM0111355

Synonyms (55)

Synonym
helaktyn pure blue fr
ostazin brilliant blue s-r
nsc 364368
einecs 236-363-9
procion blue mx-r
2-anthracenesulfonic acid, 1-amino-4-((3-((4,6-dichloro-1,3,5-triazin-2-yl)amino)-4-sulfophenyl)amino)-9,10-dihydro-9,10-dioxo-
procion brilliant blue mx-r
mikacion brilliant blue rs
procion brilliant blue rs
brn 0602258
procion brilliant blue mr
c.i. 61205
reactive blue 4
modr reaktivni 4 [czech]
2-anthracenesulfonic acid, 1-amino-4-(3-((4,6-dichloro-s-triazin-2-yl)amino)-4-sulfoanilino)-9,10-dihydro-9,10-dioxo-
13324-20-4
nsc-364368
nsc364368
c.i. reactive blue 4
1-amino-4-[3-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-4-sulfo-anilino]-9,10-dioxo-anthracene-2-sulfonic acid
1-amino-4-({3-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-4-sulfophenyl}amino)-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid
reactive blue 4-agarose, saline suspension
reactive blue 4-agarose, lyophilized powder (stabilized with lactose)
reactive blue 4-agarose, prepacked column
reactive blue 4, dye content 35 %
1-amino-4-[3-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-4-sulfoanilino]-9,10-dioxoanthracene-2-sulfonic acid
1-amino-4-(2'-(4',6'-dichloro-s-triazin-2-yl)amino)phenylamino)9,10-dihydro-9,10-dioxoanthracene-2,4'-disulphonic acid
modr reaktivni 4
FT-0688142
2-anthracenesulfonic acid, 1-amino-4-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-4-sulfophenyl]amino]-9,10-dihydro-9,10-dioxo-
SCHEMBL430581
DTXSID2065412
CHEMBL1741102
mfcd00001218
reactive blue 4, dye content ca 40%
AKOS030228255
1-amino-4-((3-((4,6-dichloro-1,3,5-triazin-2-yl)amino)-4-sulfophenyl)amino)-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid ,
J-006337
A934805
reactive blue 4 dye content 35%
1-amino-4-(3-(4,6-dichloro-1,3,5-triazin-2-ylamino)-4-sulfophenylamino)-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid
HY-125815
CS-0100024
reactive brilliant blue x-br
MS-30894
blue
procion
PD054618
helaktyn blue fr
brilliant blue x-br 140
2-anthraquinonesulfonic acid, 1-amino-4-[3-[(4,6-dichloro-s-triazin-2-yl)amino]-4-sulfoanilino]-
reactive blue mr
M3J92M47JZ
1-amino-4-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-4-sulfophenyl]amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid
sigma reactive blue 4

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Decolorization of the two anthraquinone dyes was investigated to evaluate the rate and extent of color removal as well as to assess possible toxic effects of the dyes and their decolorization product(s) on the methanogenic culture as a function of initial dye concentration ranging from 50 to 300 mg x L(-1)."( Decolorization and toxicity of reactive anthraquinone textile dyes under methanogenic conditions.
Lee, YH; Pavlostathis, SG, 2004
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (44)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (6.82)18.7374
1990's3 (6.82)18.2507
2000's19 (43.18)29.6817
2010's14 (31.82)24.3611
2020's5 (11.36)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 16.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index16.60 (24.57)
Research Supply Index3.81 (2.92)
Research Growth Index5.23 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (16.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other44 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]